1 | hemoglobin | 5,352 |
2 | haemoglobin | 1,894 |
3 | trough | 1,239 |
4 | hematocrit | 907 |
5 | life-years | 484 |
6 | haematocrit | 232 |
7 | post-bronchodilator | 138 |
8 | postbronchodilator | 55 |
9 | pre-bronchodilator | 46 |
10 | prebronchodilator | 43 |
11 | glycohemoglobin | 38 |
12 | out-of-range | 31 |
13 | percent-predicted | 16 |
14 | intervisit | 15 |
15 | ribulose-1,5-bisphosphate | 15 |
16 | life-days | 10 |
17 | δpeak | 10 |
18 | gcf-pge | 9 |
19 | one-second | 9 |
20 | rs8050136 | 9 |
21 | sil-2rα | 9 |
22 | 1-sec | 8 |
23 | body-mass-index | 8 |
24 | recombivax | 8 |
25 | triglicerides | 8 |
26 | life-months | 7 |
27 | post-alt | 7 |
28 | post-evh | 7 |
29 | pre-prandial | 7 |
30 | ferritinaemia | 6 |
31 | fev1/ | 6 |
32 | hemoglobulin | 6 |
33 | hiv1-rna | 6 |
34 | igf-1sds | 6 |
35 | 25-hydroxyvitamin-d | 5 |
36 | laboratory-measured | 5 |
37 | polyox | 5 |
38 | radiocesium | 5 |
39 | smica/b | 5 |
40 | sub-national | 5 |
41 | 258.4 | 4 |
42 | 3.6-point | 4 |
43 | desynchrony | 4 |
44 | f-doped | 4 |
45 | flow-flux | 4 |
46 | hemoglobine | 4 |
47 | hot35 | 4 |
48 | jas2007gl | 4 |
49 | ldlcholesterol | 4 |
50 | lifeyears | 4 |
51 | percent-of-predicted | 4 |
52 | zip-code | 4 |
53 | 2,641 | 3 |
54 | cryptotympana | 3 |
55 | hemotocrit | 3 |
56 | kulanite | 3 |
57 | oleoylethanolamide | 3 |
58 | post-massage | 3 |
59 | post-β-agonist | 3 |
60 | s-desmethylcitalopram | 3 |
61 | weighted-mean | 3 |
62 | 9-fluorenylmethoxycarbonyl | 2 |
63 | d3mfs | 2 |
64 | dose/plasma | 2 |
65 | end-trial | 2 |
66 | enteroglucagon | 2 |
67 | forced-dissipative | 2 |
68 | haemoglobine | 2 |
69 | heamoglobin | 2 |
70 | heliomolar | 2 |
71 | keggin-type | 2 |
72 | oxyprem | 2 |
73 | ribulose-1,5-biphosphate | 2 |
74 | suśrutasa | 2 |
75 | three-alternative | 2 |
76 | volume-high | 2 |
77 | -1,400 | 1 |
78 | -436.4 | 1 |
79 | -diphosphoglycerate | 1 |
80 | 0.0740 | 1 |
81 | 10.794 | 1 |
82 | 400-500ms | 1 |
83 | 47,798 | 1 |
84 | 75-db | 1 |
85 | air-alcohol | 1 |
86 | animal-population | 1 |
87 | asheville | 1 |
88 | bed/day | 1 |
89 | below-castration | 1 |
90 | biomasss | 1 |
91 | bleeding.the | 1 |
92 | chitosan/tmc | 1 |
93 | comma-separated | 1 |
94 | controlled/uncontrolled | 1 |
95 | cost/delta | 1 |
96 | dct-gat | 1 |
97 | deep-donor | 1 |
98 | dft/b3lyp/6-31g** | 1 |
99 | di-o-isopropylidene-α-d-glucofuranose | 1 |
100 | e-rfc | 1 |
101 | extracelullar | 1 |
102 | fat-free-mass-adjusted | 1 |
103 | fpg-independent | 1 |
104 | friedewald-estimated | 1 |
105 | fructosamin | 1 |
106 | gestationalglucose | 1 |
107 | glucose/hemoglobin | 1 |
108 | gold-acceptable | 1 |
109 | haemaglobin | 1 |
110 | haemoglogin | 1 |
111 | hemaglobin | 1 |
112 | hemoglobin/hemoglobin | 1 |
113 | hemogoloin | 1 |
114 | intensive-arm | 1 |
115 | jas-defined | 1 |
116 | jbs-2 | 1 |
117 | kcat/km=0.88 | 1 |
118 | ldl-cholesterol-plasma | 1 |
119 | ldl/sdldl | 1 |
120 | lexa | 1 |
121 | life-month | 1 |
122 | llano | 1 |
123 | lv- | 1 |
124 | ly/qaly | 1 |
125 | lymph/plasma | 1 |
126 | measures-maximum | 1 |
127 | mptp+ | 1 |
128 | n-banding | 1 |
129 | nause- | 1 |
130 | nct-measured | 1 |
131 | ofpopulation | 1 |
132 | pbtx/cell | 1 |
133 | per-refill | 1 |
134 | pre-bronchodilation | 1 |
135 | pre-meal/bedtime | 1 |
136 | pre-peak | 1 |
137 | r-max | 1 |
138 | sagie-framingham-corrected | 1 |
139 | saliva-plasma | 1 |
140 | school-class | 1 |
141 | serum-acetate | 1 |
142 | sm-added | 1 |
143 | snrs/dnrs | 1 |
144 | toenail-to-plasma | 1 |
145 | v50/v25 | 1 |
146 | ve/ | 1 |
147 | vegf-3 | 1 |
148 | vision-year | 1 |
149 | vitalcapacity | 1 |
150 | work-capacity | 1 |
151 | £1.41 | 1 |
152 | ±lv | 1 |
153 | δtmax | 1 |
154 | €9277/qaly | 1 |
1 | -1,400 | 1 |
2 | -436.4 | 1 |
3 | -diphosphoglycerate | 1 |
4 | 0.0740 | 1 |
5 | 1-sec | 8 |
6 | 10.794 | 1 |
7 | 2,641 | 3 |
8 | 25-hydroxyvitamin-d | 5 |
9 | 258.4 | 4 |
10 | 3.6-point | 4 |
11 | 400-500ms | 1 |
12 | 47,798 | 1 |
13 | 75-db | 1 |
14 | 9-fluorenylmethoxycarbonyl | 2 |
15 | air-alcohol | 1 |
16 | animal-population | 1 |
17 | asheville | 1 |
18 | bed/day | 1 |
19 | below-castration | 1 |
20 | biomasss | 1 |
21 | bleeding.the | 1 |
22 | body-mass-index | 8 |
23 | chitosan/tmc | 1 |
24 | comma-separated | 1 |
25 | controlled/uncontrolled | 1 |
26 | cost/delta | 1 |
27 | cryptotympana | 3 |
28 | d3mfs | 2 |
29 | dct-gat | 1 |
30 | deep-donor | 1 |
31 | desynchrony | 4 |
32 | dft/b3lyp/6-31g** | 1 |
33 | di-o-isopropylidene-α-d-glucofuranose | 1 |
34 | dose/plasma | 2 |
35 | e-rfc | 1 |
36 | end-trial | 2 |
37 | enteroglucagon | 2 |
38 | extracelullar | 1 |
39 | f-doped | 4 |
40 | fat-free-mass-adjusted | 1 |
41 | ferritinaemia | 6 |
42 | fev1/ | 6 |
43 | flow-flux | 4 |
44 | forced-dissipative | 2 |
45 | fpg-independent | 1 |
46 | friedewald-estimated | 1 |
47 | fructosamin | 1 |
48 | gcf-pge | 9 |
49 | gestationalglucose | 1 |
50 | glucose/hemoglobin | 1 |
51 | glycohemoglobin | 38 |
52 | gold-acceptable | 1 |
53 | haemaglobin | 1 |
54 | haematocrit | 232 |
55 | haemoglobin | 1,894 |
56 | haemoglobine | 2 |
57 | haemoglogin | 1 |
58 | heamoglobin | 2 |
59 | heliomolar | 2 |
60 | hemaglobin | 1 |
61 | hematocrit | 907 |
62 | hemoglobin | 5,352 |
63 | hemoglobin/hemoglobin | 1 |
64 | hemoglobine | 4 |
65 | hemoglobulin | 6 |
66 | hemogoloin | 1 |
67 | hemotocrit | 3 |
68 | hiv1-rna | 6 |
69 | hot35 | 4 |
70 | igf-1sds | 6 |
71 | intensive-arm | 1 |
72 | intervisit | 15 |
73 | jas-defined | 1 |
74 | jas2007gl | 4 |
75 | jbs-2 | 1 |
76 | kcat/km=0.88 | 1 |
77 | keggin-type | 2 |
78 | kulanite | 3 |
79 | laboratory-measured | 5 |
80 | ldl-cholesterol-plasma | 1 |
81 | ldl/sdldl | 1 |
82 | ldlcholesterol | 4 |
83 | lexa | 1 |
84 | life-days | 10 |
85 | life-month | 1 |
86 | life-months | 7 |
87 | life-years | 484 |
88 | lifeyears | 4 |
89 | llano | 1 |
90 | lv- | 1 |
91 | ly/qaly | 1 |
92 | lymph/plasma | 1 |
93 | measures-maximum | 1 |
94 | mptp+ | 1 |
95 | n-banding | 1 |
96 | nause- | 1 |
97 | nct-measured | 1 |
98 | ofpopulation | 1 |
99 | oleoylethanolamide | 3 |
100 | one-second | 9 |
101 | out-of-range | 31 |
102 | oxyprem | 2 |
103 | pbtx/cell | 1 |
104 | per-refill | 1 |
105 | percent-of-predicted | 4 |
106 | percent-predicted | 16 |
107 | polyox | 5 |
108 | post-alt | 7 |
109 | post-bronchodilator | 138 |
110 | post-evh | 7 |
111 | post-massage | 3 |
112 | post-β-agonist | 3 |
113 | postbronchodilator | 55 |
114 | pre-bronchodilation | 1 |
115 | pre-bronchodilator | 46 |
116 | pre-meal/bedtime | 1 |
117 | pre-peak | 1 |
118 | pre-prandial | 7 |
119 | prebronchodilator | 43 |
120 | r-max | 1 |
121 | radiocesium | 5 |
122 | recombivax | 8 |
123 | ribulose-1,5-biphosphate | 2 |
124 | ribulose-1,5-bisphosphate | 15 |
125 | rs8050136 | 9 |
126 | s-desmethylcitalopram | 3 |
127 | sagie-framingham-corrected | 1 |
128 | saliva-plasma | 1 |
129 | school-class | 1 |
130 | serum-acetate | 1 |
131 | sil-2rα | 9 |
132 | sm-added | 1 |
133 | smica/b | 5 |
134 | snrs/dnrs | 1 |
135 | sub-national | 5 |
136 | suśrutasa | 2 |
137 | three-alternative | 2 |
138 | toenail-to-plasma | 1 |
139 | triglicerides | 8 |
140 | trough | 1,239 |
141 | v50/v25 | 1 |
142 | ve/ | 1 |
143 | vegf-3 | 1 |
144 | vision-year | 1 |
145 | vitalcapacity | 1 |
146 | volume-high | 2 |
147 | weighted-mean | 3 |
148 | work-capacity | 1 |
149 | zip-code | 4 |
150 | £1.41 | 1 |
151 | ±lv | 1 |
152 | δpeak | 10 |
153 | δtmax | 1 |
154 | €9277/qaly | 1 |
1 | dft/b3lyp/6-31g** | 1 |
2 | mptp+ | 1 |
3 | nause- | 1 |
4 | lv- | 1 |
5 | fev1/ | 6 |
6 | ve/ | 1 |
7 | -1,400 | 1 |
8 | 0.0740 | 1 |
9 | £1.41 | 1 |
10 | 2,641 | 3 |
11 | jbs-2 | 1 |
12 | vegf-3 | 1 |
13 | -436.4 | 1 |
14 | 258.4 | 4 |
15 | 10.794 | 1 |
16 | v50/v25 | 1 |
17 | hot35 | 4 |
18 | rs8050136 | 9 |
19 | kcat/km=0.88 | 1 |
20 | 47,798 | 1 |
21 | ferritinaemia | 6 |
22 | saliva-plasma | 1 |
23 | ldl-cholesterol-plasma | 1 |
24 | toenail-to-plasma | 1 |
25 | dose/plasma | 2 |
26 | lymph/plasma | 1 |
27 | cryptotympana | 3 |
28 | hiv1-rna | 6 |
29 | suśrutasa | 2 |
30 | cost/delta | 1 |
31 | lexa | 1 |
32 | smica/b | 5 |
33 | 75-db | 1 |
34 | 1-sec | 8 |
35 | e-rfc | 1 |
36 | chitosan/tmc | 1 |
37 | 25-hydroxyvitamin-d | 5 |
38 | sm-added | 1 |
39 | controlled/uncontrolled | 1 |
40 | jas-defined | 1 |
41 | f-doped | 4 |
42 | nct-measured | 1 |
43 | laboratory-measured | 5 |
44 | friedewald-estimated | 1 |
45 | comma-separated | 1 |
46 | sagie-framingham-corrected | 1 |
47 | percent-of-predicted | 4 |
48 | percent-predicted | 16 |
49 | fat-free-mass-adjusted | 1 |
50 | one-second | 9 |
51 | oleoylethanolamide | 3 |
52 | zip-code | 4 |
53 | post-massage | 3 |
54 | out-of-range | 31 |
55 | gcf-pge | 9 |
56 | bleeding.the | 1 |
57 | gold-acceptable | 1 |
58 | asheville | 1 |
59 | pre-meal/bedtime | 1 |
60 | haemoglobine | 2 |
61 | hemoglobine | 4 |
62 | keggin-type | 2 |
63 | gestationalglucose | 1 |
64 | di-o-isopropylidene-α-d-glucofuranose | 1 |
65 | ribulose-1,5-biphosphate | 2 |
66 | ribulose-1,5-bisphosphate | 15 |
67 | -diphosphoglycerate | 1 |
68 | serum-acetate | 1 |
69 | kulanite | 3 |
70 | three-alternative | 2 |
71 | forced-dissipative | 2 |
72 | n-banding | 1 |
73 | volume-high | 2 |
74 | trough | 1,239 |
75 | life-month | 1 |
76 | post-evh | 7 |
77 | pre-peak | 1 |
78 | δpeak | 10 |
79 | pre-prandial | 7 |
80 | end-trial | 2 |
81 | sub-national | 5 |
82 | ldl/sdldl | 1 |
83 | jas2007gl | 4 |
84 | pbtx/cell | 1 |
85 | per-refill | 1 |
86 | air-alcohol | 1 |
87 | ldlcholesterol | 4 |
88 | 9-fluorenylmethoxycarbonyl | 2 |
89 | s-desmethylcitalopram | 3 |
90 | oxyprem | 2 |
91 | intensive-arm | 1 |
92 | radiocesium | 5 |
93 | measures-maximum | 1 |
94 | weighted-mean | 3 |
95 | haemaglobin | 1 |
96 | hemaglobin | 1 |
97 | heamoglobin | 2 |
98 | haemoglobin | 1,894 |
99 | hemoglobin | 5,352 |
100 | glucose/hemoglobin | 1 |
101 | hemoglobin/hemoglobin | 1 |
102 | glycohemoglobin | 38 |
103 | haemoglogin | 1 |
104 | hemoglobulin | 6 |
105 | fructosamin | 1 |
106 | hemogoloin | 1 |
107 | enteroglucagon | 2 |
108 | pre-bronchodilation | 1 |
109 | animal-population | 1 |
110 | ofpopulation | 1 |
111 | below-castration | 1 |
112 | llano | 1 |
113 | vision-year | 1 |
114 | extracelullar | 1 |
115 | heliomolar | 2 |
116 | deep-donor | 1 |
117 | pre-bronchodilator | 46 |
118 | post-bronchodilator | 138 |
119 | prebronchodilator | 43 |
120 | postbronchodilator | 55 |
121 | igf-1sds | 6 |
122 | triglicerides | 8 |
123 | d3mfs | 2 |
124 | life-months | 7 |
125 | 400-500ms | 1 |
126 | life-years | 484 |
127 | lifeyears | 4 |
128 | snrs/dnrs | 1 |
129 | school-class | 1 |
130 | biomasss | 1 |
131 | life-days | 10 |
132 | dct-gat | 1 |
133 | haematocrit | 232 |
134 | hematocrit | 907 |
135 | hemotocrit | 3 |
136 | intervisit | 15 |
137 | post-alt | 7 |
138 | fpg-independent | 1 |
139 | 3.6-point | 4 |
140 | post-β-agonist | 3 |
141 | ±lv | 1 |
142 | r-max | 1 |
143 | δtmax | 1 |
144 | recombivax | 8 |
145 | body-mass-index | 8 |
146 | polyox | 5 |
147 | flow-flux | 4 |
148 | bed/day | 1 |
149 | €9277/qaly | 1 |
150 | ly/qaly | 1 |
151 | desynchrony | 4 |
152 | work-capacity | 1 |
153 | vitalcapacity | 1 |
154 | sil-2rα | 9 |